On Wednesday, August 28th, at 12pm CST (10am PST/11 am MST/1pm EST) Cure SMA will host a webinar to provide updates on Zolgensma. The webinar will be divided into three separate sections. We’re pleased to have representatives from the FDA, Cure SMA, and AveXis, a Novartis Company, participating to share information and answer questions.
Panelists for the webinar include:
- Dr. Peter Marks, M.D. Ph.D., Director, Center for Biologics Evaluation and Research (CBER) at FDA
- Kenneth Hobby, President at Cure SMA and Mary Schroth, MD, Chief Medical Officer at Cure SMA
- Dave Lennon, President of AveXis, a Novartis Company
The 60-minute webinar will also include a Q&A session. Please submit your questions by 12pm CST on Tuesday, August 27th, so that we can plan to answer as many of them as possible. Note that we may not read all questions submitted during the webinar. Questions can be submitted on the webinar registration page.
We look forward to you joining us!
This webinar is intended for U.S. audiences only.